DK1140090T3 - Anvendelse af phanquinon til behandlingen eller hindringen af hukommelsessvigt - Google Patents

Anvendelse af phanquinon til behandlingen eller hindringen af hukommelsessvigt

Info

Publication number
DK1140090T3
DK1140090T3 DK00900025T DK00900025T DK1140090T3 DK 1140090 T3 DK1140090 T3 DK 1140090T3 DK 00900025 T DK00900025 T DK 00900025T DK 00900025 T DK00900025 T DK 00900025T DK 1140090 T3 DK1140090 T3 DK 1140090T3
Authority
DK
Denmark
Prior art keywords
phanquinone
prevention
treatment
memory failure
failure
Prior art date
Application number
DK00900025T
Other languages
English (en)
Inventor
Michel Xilinas
Panayotis Nikolas Gerolymatos
Original Assignee
Gerolymatos P N Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gerolymatos P N Sa filed Critical Gerolymatos P N Sa
Application granted granted Critical
Publication of DK1140090T3 publication Critical patent/DK1140090T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DK00900025T 1999-01-07 2000-01-06 Anvendelse af phanquinon til behandlingen eller hindringen af hukommelsessvigt DK1140090T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GR99100005 1999-01-07
PCT/IB2000/000011 WO2000040244A1 (en) 1999-01-07 2000-01-06 Use of phanquinone for the treatment or prevention of memory impairment
EP00900025A EP1140090B1 (en) 1999-01-07 2000-01-06 Use of phanquinone for the treatment or prevention of memory impairment

Publications (1)

Publication Number Publication Date
DK1140090T3 true DK1140090T3 (da) 2005-04-18

Family

ID=10943706

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00900025T DK1140090T3 (da) 1999-01-07 2000-01-06 Anvendelse af phanquinon til behandlingen eller hindringen af hukommelsessvigt

Country Status (17)

Country Link
US (1) US7030136B2 (da)
EP (1) EP1140090B1 (da)
JP (1) JP2002534386A (da)
AR (1) AR022215A1 (da)
AT (1) ATE285235T1 (da)
AU (1) AU1792200A (da)
BR (1) BR0008241A (da)
CA (1) CA2358487C (da)
DE (1) DE60016892T2 (da)
DK (1) DK1140090T3 (da)
ES (1) ES2234559T3 (da)
HK (1) HK1042039B (da)
IL (1) IL143903A (da)
PT (1) PT1140090E (da)
SI (1) SI1140090T1 (da)
TR (1) TR200101892T2 (da)
WO (1) WO2000040244A1 (da)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999009981A1 (en) 1997-08-21 1999-03-04 P.N. Gerolymatos S.A. Use of phanquinone for the treatment of alzheimer's disease
AU2001250573A1 (en) * 2000-04-28 2001-11-12 Michel Xilinas Treatment of pathological conditions influenced by the action of matrix metalloproteinases (mmps) using phanquinone
RU2192861C1 (ru) * 2001-06-29 2002-11-20 Новосибирский институт биоорганической химии СО РАН Композиция для антибластической терапии

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1472257A (en) 1973-09-10 1977-05-04 Christiaens Sa A Derivative of 4-hydroxy-5-azacoumarin
JP2608078B2 (ja) * 1986-12-17 1997-05-07 グラクソ、グループ、リミテッド 医 薬
US5091391A (en) * 1990-08-16 1992-02-25 University Of Pittsburgh Of The Commonwealth System Of Higher Education Method of resisting neurodegenerative disorders
JP3277211B2 (ja) 1991-11-12 2002-04-22 プラナ・バイオテクノロジー・リミテッド アルツハイマー病の試験方法と治療方法
US5866597A (en) * 1993-03-19 1999-02-02 Glaxo Wellcome Inc. Use of triazine compounds for the treatment of memory and learning disorders
US5792774A (en) * 1996-02-21 1998-08-11 Chiroscience Limited Quinolones and their therapeutic use
WO1997046526A1 (en) 1996-06-07 1997-12-11 Eisai Co., Ltd. Stable polymorphs of donepezil (1-benzyl-4-[(5,6-dimethoxy-1-indanon)-2-yl]methylpiperidine) hydrochloride and process for production
CZ295118B6 (cs) * 1996-08-13 2005-05-18 P. N. Gerolymatos S. A. Farmaceutický prostředek
JP2001514661A (ja) 1997-03-11 2001-09-11 ザ ジェネラル ホスピタル コーポレイション アルツハイマー病の処置における使用のための薬剤の同定
WO1999009981A1 (en) * 1997-08-21 1999-03-04 P.N. Gerolymatos S.A. Use of phanquinone for the treatment of alzheimer's disease
US5980914A (en) * 1997-08-22 1999-11-09 P.N. Gerolymatos S.A. Clioquinol for the treatment of Parkinson's disease
US5994323A (en) * 1997-12-31 1999-11-30 P.N. Gerolymatos S.A. Pharmaceutical compositions comprising clioquinol in combination with vitamin B12 and therapeutic and prophylactic uses thereof

Also Published As

Publication number Publication date
JP2002534386A (ja) 2002-10-15
PT1140090E (pt) 2005-05-31
US7030136B2 (en) 2006-04-18
BR0008241A (pt) 2001-10-30
TR200101892T2 (tr) 2001-11-21
WO2000040244A1 (en) 2000-07-13
CA2358487C (en) 2008-11-18
EP1140090A1 (en) 2001-10-10
ES2234559T3 (es) 2005-07-01
AU1792200A (en) 2000-07-24
ATE285235T1 (de) 2005-01-15
DE60016892D1 (de) 2005-01-27
IL143903A (en) 2004-02-08
AR022215A1 (es) 2002-09-04
EP1140090B1 (en) 2004-12-22
CA2358487A1 (en) 2000-07-13
HK1042039B (en) 2005-07-29
DE60016892T2 (de) 2005-12-15
HK1042039A1 (en) 2002-08-02
IL143903A0 (en) 2002-04-21
SI1140090T1 (en) 2005-06-30
US20030055078A1 (en) 2003-03-20

Similar Documents

Publication Publication Date Title
DK1427437T3 (da) Oxyntomodulin til forebyggelse eller behandling af overvægt
DK1144395T3 (da) 2-amino-benzoxazinon-derivater til behandling af fedme
DK1181027T3 (da) Diætetisk eller farmaceutisk præparat til anvendelse til forebyggelsen eller behandling af hyperoxaluri
DK1147083T3 (da) Arylpiperazinyl-cyclohexylindolderivater til behandling af depression
DK2412368T3 (da) Sammensætning til behandling af ar
NO20014379D0 (no) Anvendelse av Xenon for behandling av Neurointoksikasjoner
NO20013381D0 (no) 2-oksybenzoksazinonderivater for behandling av fedme
DK1196163T3 (da) Farmaceutiske sammensætninger til behandling af insulinresistens
DK1063990T3 (da) Anvendelse af Biochanin-beriget ekstrakt til behandling af östrogen-associerede lidelser
NO995500L (no) Anvendelse av en farmasøytisk sammensetning til behandling av/eller forhindring av ischemi
NO990722D0 (no) FremgangsmÕte for behandling av hjertesvikt
DK1278540T3 (da) Anvendelse af IL-18-inhibitorer til behandling og/eller forebyggelsen af aterosklerose
DK199800837A (da) Anlæg til behandling af emner
DK1411917T3 (da) Carbamatforbindelser til anvendelse til forebyggelse eller behandling af bevægelsesforstyrrelser
DK1041985T3 (da) Kombination af benzocycloheptapyridinforbindelser og antineoplastiske lægemidler til behandling af profilerative sygdomme
DK1218022T3 (da) Sammensætning til forebyggelse og/eller behandling af kredsløbslidelser omfattende derivater af L-carnitin og ekstrakter af Ginkgo Biloba
DK1173179T3 (da) Anvendelse af saredutant og de farmaceutisk acceptable salte heraf til behandling eller forebyggelse af svær depressiv forstyrrelse
DK1534296T3 (da) Anvendelse af cilobradin eller de farmaceutisk acceptable salte deraf til behandling eller forebyggelse af hjertesvigt
DK1140090T3 (da) Anvendelse af phanquinon til behandlingen eller hindringen af hukommelsessvigt
DK1607090T3 (da) Asimadolin til behandling af irritabel tyktarm (Irritable Bowel Syndrome)
DK1032559T3 (da) Aminoalkylphenolderivater til behandling af depression og hukommelsessvigt
DK1157987T3 (da) S-nitrosothioler som midler til behandling af kredsløbsforstyrrelser
DK1064014T3 (da) Lægemiddel til forebyggelse eller behandling af papillomvirusspecifik tumor
DK199900400U3 (da) System til beskyttelse af træværk
DE50004776D1 (de) Bauelement zur Errichtung von Regalen